JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5351
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
$198M
| $66.7K | ﹤0.01% |
+1,920
| New | +$65.6K |
2023 Q1
0 quarters
|
|
|
TBHC
5352
DELISTED
The Brand House Collective
TBHC
| $66K | ﹤0.01% |
23,199
-3,808
| -14% | -$12.6K |
2020 Q2
11 quarters
|
|
|
PIM
5353
Franklin Master Intermediate Income Trust
PIM
$143M
| $66K | ﹤0.01% |
+20,906
| New | +$68K |
2023 Q1
0 quarters
|
|
|
SNMP
5354
DELISTED
Evolve Transition Infrastructure LP
SNMP
| $66K | ﹤0.01% |
10,899
| – | – |
2022 Q2
3 quarters
|
|
5355
AGF US Market Neutral Anti-Beta Fund
BTAL
$310M
| $65.6K | ﹤0.01% |
3,217
+2,732
| +563% | +$55K |
2022 Q4
1 quarter
|
|
5356
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.33B
| $65.6K | ﹤0.01% |
729
| – | – |
2022 Q4
1 quarter
|
|
|
LGHL
5357
Lion Group Holding
LGHL
$177K
| – | – |
0
| – | – |
2021 Q1
8 quarters
|
|
5358
Westlake Chemical Partners
WLKP
$755M
| $65K | ﹤0.01% |
2,959
+36
| +1% | +$844 |
2021 Q3
6 quarters
|
|
5359
Innovator US Equity Power Buffer ETF December
PDEC
$996M
| $65K | ﹤0.01% |
2,066
| – | – |
2022 Q4
1 quarter
|
|
5360
FT Vest International Equity Moderate Buffer ETF March
YMAR
$163M
| $64.6K | ﹤0.01% |
+3,124
| New | +$61.7K |
2023 Q1
0 quarters
|
|
|
AVK
5361
Advent Convertible and Income Fund
AVK
$509M
| $64.6K | ﹤0.01% |
5,696
-809
| -12% | -$9.51K |
2022 Q4
1 quarter
|
|
5362
PUT
Peabody Energy
BTU
$3.11B
| $64K | ﹤0.01% |
+2,500
| New | +$66.4K |
2023 Q1
0 quarters
|
|
|
DHF
5363
BNY Mellon High Yield Strategies Fund
DHF
$162M
| $64K | ﹤0.01% |
+29,793
| New | +$66.8K |
2023 Q1
0 quarters
|
|
|
FRGE
5364
DELISTED
Forge Global Holdings
FRGE
| $64K | ﹤0.01% |
+2,450
| New | +$66.5K |
2023 Q1
0 quarters
|
|
5365
PUT
Hasbro
HAS
$13B
| $64K | ﹤0.01% |
+1,200
| New | +$68.6K |
2023 Q1
0 quarters
|
|
5366
PUT
Super Micro Computer
SMCI
$28.4B
| $64K | ﹤0.01% |
+6,000
| New | +$54.1K |
2023 Q1
0 quarters
|
|
|
VRNA
5367
CALL
DELISTED
Verona Pharma
VRNA
| $64K | ﹤0.01% |
+3,200
| New | +$69.1K |
2023 Q1
0 quarters
|
|
|
FRBK
5368
DELISTED
Republic First Bancorp Inc
FRBK
| $64K | ﹤0.01% |
47,423
+8,317
| +21% | +$16.3K |
2017 Q4
21 quarters
|
|
5369
Opus Small Cap Value ETF
OSCV
$628M
| $63.9K | ﹤0.01% |
2,051
-49
| -2% | -$1.56K |
2022 Q4
1 quarter
|
|
|
THRD
5370
DELISTED
Third Harmonic Bio
THRD
| $63K | ﹤0.01% |
15,266
-3,612
| -19% | -$15.3K |
2022 Q4
1 quarter
|
|
5371
Westrock Coffee
WEST
$802M
| $63K | ﹤0.01% |
5,170
+1,400
| +37% | +$17.2K |
2022 Q3
2 quarters
|
|
|
IMGN
5372
PUT
DELISTED
Immunogen Inc
IMGN
| $63K | ﹤0.01% |
+16,400
| New | +$69.9K |
2023 Q1
0 quarters
|
|
|
LTCH
5373
DELISTED
Latch, Inc. Common Stock
LTCH
| $63K | ﹤0.01% |
83,262
+18,230
| +28% | +$15K |
2021 Q3
6 quarters
|
|
5374
First Trust Emerging Markets AlphaDEX Fund
FEM
$828M
| $62.8K | ﹤0.01% |
2,941
+2,854
| +3,280% | +$61.4K |
2022 Q4
1 quarter
|
|
5375
GraniteShares Gold Shares
BAR
$1.35B
| $62.6K | ﹤0.01% |
3,217
+264
| +9% | +$4.95K |
2021 Q1
8 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.